期刊文献+

过氧化物酶体增殖物激活受体-γ激动剂对高脂喂养SD大鼠血清视黄醇结合蛋白4水平的影响

The infulence of PPAR-γagonists on serum RBP4 level in SD rats fed high-fat diet
原文传递
导出
摘要 目的观察高脂喂养及吡咯列酮干预对SD大鼠视黄醇结合蛋白4(RBP4)水平的影响。方法雄性SD大鼠随机分为3组,分别给予普通饮食(NC组)、高脂(F组)及高脂吡咯列酮(F+Pio组)干预,第8、12周时行OGTT及胰岛素释放试验(ITT),评价胰岛功能。检测FPG、血脂、肝功能及血清RBP4水平,并对肝脏、附睾脂肪和肾周脂肪称重,计算肝脏质量/体质量及脂肪质量/体质量。结果8周后,F组FPG、血脂、胰岛素及OGTT血糖曲线下面积(AUCOGTT)、AUCITT均高于NC组(P<0.05或P<0.01),血清RBP4水平升高(P<0.01);12周后,与F组相比,F+Pio组FPG、胰岛素、TG、TC、AUCOGTT、AUCITT、肝脏质量/体质量及脂肪质量/体质量和血清RBP4水平降低(P<0.05或P<0.01)。结论 PPAR-γ激动剂吡咯列酮能减轻糖脂毒性、改善IR并降低体内RBP4水平。 Objective To observe the impact of PPAR-γ agonist pioglitazone on serum RBP4 levels in SD rats fed high-fat diet.Methods Male SD rats were randomly divided into 3 groups:normal diet group,high fat diet group,high fat diet plus pioglitazone treatment group.At 8 and 12 weeks,oral glucose tolerance test (OGTT)and insulin-releasing test were performed to assay islet function.Also fasting blood glucose,lipid profiles,liver function,RBP4 levels were measured.Epididymal fat,perirenal fat,liver were weighed respectively for calculating fat to body weight ratio and liver to body weight ratio.Results After 8 weeks,fasting blood glucose,blood lipids,insulin,the area under curves (AUC) for glucose and for insulin were all higher in high fat diet group than in normal diet group.And serum RBP4 levels were also significantly higher in high fat diet groups than in normal diet group [(58.3 ±12.7)vs (26.8±7.3)ng/ml,P<0.01].After 12 weeks,as compared with the high fat diet control group,high fat diet plus pioglitazone treatment group had lower levels of fasting blood glucose,insulin,triglycerides,total cholesterol levels,blood'glucose area and insulin area under curve during OGTT as well as fat to body weight ratio,liver to body weight ratio (P<0.01 or P<0.05).Also,serum RBP4 levels were decreased significantly[(30.3±13.9) vs(78.3±14.6)ng/ml,P<0.01].Conclusion PPAR-γagonist pioglitazone can significantly decrease serum RBP4 levels,meanwhile,significantly reduce the glucose and lipid toxicity,improve insulin resistance,and decrease RBP4 levels.
机构地区 [
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第12期1122-1125,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金(30670989)
关键词 视黄醇结合蛋白4 胰岛素抵抗 腹内脂肪 过氧化物酶体增殖物激活受体-γ激动剂 Retinol binding protein 4 (RBP4) Insulin resistance (IR) Intra-abdominal fat Peroxisome proliferator-activated receptor-γ(PPAR-γ) agonist
  • 相关文献

参考文献5

  • 1Graham TE,Yang Q,Blüher M. Retinol-binding protein 4 and insulin resistance in lean,obese,and diabetic subjects[J].NEJM,2006.2552-2563.
  • 2William D,Carlos A,Thomas M. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes[J].NEJM,2009.129-139.
  • 3Kubota N,Terauchi Y,Kubota T. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and-independent pathways[J].{H}Journal of Biological Chemistry,2006.8748-8755.
  • 4Qin Y,Timothy E,Graham. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J].{H}NATURE,2005.356-362.
  • 5包玉倩,吴海娅,邱慧玲,朱洁华,王韧,贾伟平.罗格列酮对2型糖尿病患者血清视黄醇结合蛋白4水平及肝脏脂肪含量的影响[J].上海医学,2008,31(11):767-770. 被引量:11

二级参考文献10

  • 1王遂军,贾伟平,包玉倩,陆俊茜,方启晨,陈蕾,陆惠娟,项坤三.血清脂联素与肥胖的关系[J].中华内分泌代谢杂志,2005,21(1):36-38. 被引量:89
  • 2王韧,陈亚青,周永昌,朱洁华.超声直方图对脂肪肝诊断的初步分析[J].临床消化病杂志,2006,18(2):91-92. 被引量:20
  • 3包玉倩,贾伟平,高鑫,刘伟,邢惠莉,刘志民,盛正妍,胡仁明,宁光,邹大进,冯波,陆俊茜,周健,项坤三.评估胰岛素分泌及胰岛素敏感性选择降糖药物的临床多中心研究[J].中华内分泌代谢杂志,2007,23(2):104-109. 被引量:13
  • 4Jia W, Wu H, Bao Y, et al. Association of serum retinolbinding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab, 2007, 92: 3224-3229.
  • 5Hwang Y C, Lee E Y, Lee W J, et al. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients. Metabolism, 2008, 57:479-487.
  • 6Yang Q, Graham T E, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 2005, 436:356-362.
  • 7Wu H, Jia W, Bao Y, et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract, 2008, 79:185-190.
  • 8Rieusset J, Auwerx J, Vidal H. Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes. Biochem Biophys Res Commun, 1999, 265: 265- 271.
  • 9Stefan N, Hennige A M, Staiger H, et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care, 2007, 30: 1173-1178.
  • 10Kelly I E, Han T S, Walsh K, et al. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type2 diabetes. Diabetes Care, 1999, 22: 288-293.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部